Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Dividend is covered by FCF, though with limited buffer.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (50) × 0.40 + Growth (65) × 0.35 + Income (45) × 0.25 = 54
Dividend Yield
1.21%
Per Share (TTM)
kr 1.10
Payout Ratio
—
4Y CAGR
9.4%
Dividend Safety
Earnings Payout
Not reported
FCF Payout
30.3%
FCF Coverage
3.3x
Dividend Growth
Per Share (TTM)
kr 1.10
Growth Streak
4+ years
4Y CAGR
9.4%
Dividend Schedule
Annual DPS
kr 1.10
Quarterly DPS (est.)
~kr 0.28
Frequency
Quarterly
Annual Income / $10K
kr 121
Ex-dividend and payment dates are not available from SEC filings. Check your broker or the company's investor relations page for exact dates.
Vitrolife AB (VITR.XSTO) pays about SEK 1.10 per share per year (a yield of roughly 1.2%), profiling as a low-yield dividend grower, with a payout streak of at least 4 years. The figures below are computed from SEC filings; this is analysis, not investment advice.
Yes, Vitrolife AB pays a regular dividend of about SEK 1.10 per share per year (a yield of roughly 1.2%), typically in quarterly installments. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.
Vitrolife AB's dividend looks comfortably covered by free cash flow, with free cash flow covering the payout about 3.3 times over. Intrinsiqq scores its dividend safety at 50 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.
Vitrolife AB has raised its dividend for at least 4 years in a row, the full span of the dividend history we hold. Over the past five years the dividend has grown at roughly 9.4% a year. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.